A Phase 1 Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of the Selective Met Inhibitor, JNJ 38877605 in Subjects With Advanced or Refractory Solid Tumors.

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2007
This article has no abstract
Epistemonikos ID: e2b304b482d92dfd221e40bc5038142adf978bab
First added on: Apr 16, 2025